Cheri Grigg1,2, Danielle Palms1, Nimalie D Stone1, Nicole Gualandi1, Wendy Bamberg3, Ghinwa Dumyati4, Lee H Harrison5, Ruth Lynfield6, Joelle Nadle7, Susan Petit8, Susan Ray9, William Schaffner10, John Townes11, Isaac See1. 1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Disease Control and Environmental Epidemiology Division, Colorado Department of Public Health and Environment, Denver, Colorado. 4. Infectious Diseases Division and Center for Community Health and Prevention, University of Rochester Medical Center, Rochester, New York. 5. Department of International Health, Maryland Emerging Infections Program, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 6. Executive Office, Minnesota Department of Health, St. Paul, Minnesota. 7. Hospital Associated Infections Projects, California Emerging Infections Program, Oakland, California. 8. Epidemiology and Emerging Infections Program, Connecticut Department of Public Health, Hartford, Connecticut. 9. Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia. 10. Department of Health Policy, School of Medicine, Vanderbilt University, Nashville, Tennessee. 11. Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon.
Abstract
OBJECTIVES: To describe the epidemiology and incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in nursing home (NH) residents, which has previously not been well characterized. DESIGN: Retrospective analysis of public health surveillance data. SETTING: Healthcare facilities in 33 U.S. counties. PARTICIPANTS: Residents of the surveillance area. MEASUREMENTS: Counts of NH-onset and hospital-onset (HO) invasive MRSA infections (cultured from sterile body sites) identified from the Centers for Disease Control and Prevention Emerging Infections Program (EIP) population-based surveillance from 2009 to 2013 were compared. Demographic characteristics and risk factors of NH-onset cases were analyzed. Using NH resident-day denominators from the Centers for Medicare and Medicaid Services Skilled Nursing Facility Cost Reports, incidence of NH-onset invasive MRSA infections from facilities in the EIP area was determined. RESULTS: A total of 4,607 NH-onset and 4,344 HO invasive MRSA cases were reported. Of NH-onset cases, median age was 74, most infections were bloodstream infections, and known risk factors for infection were common: 1,455 (32%) had previous MRSA infection or colonization, 1,014 (22%) had decubitus ulcers, 1,098 (24%) had recent central venous catheters, and 1,103 (24%) were undergoing chronic dialysis; 2,499 (54%) had been discharged from a hospital in the previous 100 days. The in-hospital case-fatality rate was 19%. The 2013 pooled mean incidence of NH-onset invasive MRSA infections in the surveillance area was 2.4 per 100,000 patient-days. CONCLUSION: More NH-onset than HO cases occurred, primarily in individuals with known MRSA risk factors. These data reinforce the importance of infection prevention practices during wound and device care in NH residents, especially those with a history of MRSA infection or colonization.
OBJECTIVES: To describe the epidemiology and incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in nursing home (NH) residents, which has previously not been well characterized. DESIGN: Retrospective analysis of public health surveillance data. SETTING: Healthcare facilities in 33 U.S. counties. PARTICIPANTS: Residents of the surveillance area. MEASUREMENTS: Counts of NH-onset and hospital-onset (HO) invasive MRSA infections (cultured from sterile body sites) identified from the Centers for Disease Control and Prevention Emerging Infections Program (EIP) population-based surveillance from 2009 to 2013 were compared. Demographic characteristics and risk factors of NH-onset cases were analyzed. Using NH resident-day denominators from the Centers for Medicare and Medicaid Services Skilled Nursing Facility Cost Reports, incidence of NH-onset invasive MRSA infections from facilities in the EIP area was determined. RESULTS: A total of 4,607 NH-onset and 4,344 HO invasive MRSA cases were reported. Of NH-onset cases, median age was 74, most infections were bloodstream infections, and known risk factors for infection were common: 1,455 (32%) had previous MRSA infection or colonization, 1,014 (22%) had decubitus ulcers, 1,098 (24%) had recent central venous catheters, and 1,103 (24%) were undergoing chronic dialysis; 2,499 (54%) had been discharged from a hospital in the previous 100 days. The in-hospital case-fatality rate was 19%. The 2013 pooled mean incidence of NH-onset invasive MRSA infections in the surveillance area was 2.4 per 100,000 patient-days. CONCLUSION: More NH-onset than HO cases occurred, primarily in individuals with known MRSA risk factors. These data reinforce the importance of infection prevention practices during wound and device care in NH residents, especially those with a history of MRSA infection or colonization.
Authors: Kevin Heinze; Mohammed Kabeto; Emily Toth Martin; Marco Cassone; Liam Hicks; Lona Mody Journal: Am J Infect Control Date: 2018-11-28 Impact factor: 2.918